GlassScriptPhysician profile
Cami J Dunham
NPI 1023162120
$1,411.88
in general payments reported to CMS, 2019-2025
11 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $535 · 2022: $240 · 2023: $255 · 2024: $30.45 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $472.25 | 2021-2025 | Xeomin |
| Boston Scientific Corporation | $399.15 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Scilex Pharmaceuticals INC. | $102.12 | 2021-2022 | |
| Stryker Corporation | $92.02 | 2025 | Mild Device Kit |
| Radius Health, INC. | $74.45 | 2021-2022 | |
| Ibsa Pharma INC. | $54.81 | 2021-2022 | |
| Amgen INC. | $54.45 | 2021-2025 | Evenity |
| Nalu Medical, INC. | $54.41 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.47 | 2021 | |
| Grt US Holding, INC. | $37.78 | 2021 | |
| Medtronic, INC. | $28.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cami Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.